| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/10/2010 | US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis |
| 08/10/2010 | US7772378 inhibiting sodium-dependent glucose cotransporter SGLT2; diabetes mellitus, metabolic acidosis or ketosis, reactive hypoglycaemia, hyperinsulinaemia, glucose metabolic disorder, insulin resistance, metabolic syndrome, dyslipidaemias, atherosclerosis, obesity, high blood pressure, chronic heart failure |
| 08/10/2010 | US7772375 amyloidosis; neurological disorders such as Alzheimer's Disease |
| 08/10/2010 | US7772352 drug delivery, tissue engineering, tissue adhesives, adhesion prevention,implantable medical devices, molded article; Paracetamol; moieties of glycolic acid, lactic acid, dioxanone, caprolactone; diisocyanate derivatives of phenolic drugs are polymer monomers |
| 08/10/2010 | US7772285 Benzophenone derivatives or salts thereof |
| 08/10/2010 | US7772284 Administering organonitrogen polymers and optionally with mixtures of cyclodextrins, as viricides; enzyme inhibitors |
| 08/10/2010 | US7772283 Neuronal sodium channel antagonist in combination with macrocyclic lactone compounds; insect control and crop protection; nontoxic, environmentally friendly; low cost; reduced dosage rates |
| 08/10/2010 | US7772282 Neuronal sodium channel antagonist in combination with one or more formamidine compounds such as amitraz, chlordimeform and chlorfenamidine; plant and crop protection |
| 08/10/2010 | US7772281 Neuronal sodium channel antagonist with pyrethroids, recombinant nucleopolyhedroviruses expressing insect toxin, organophosphates, carbamates, formamidines, macrocyclic lactones, amidinohydrazones, GABA antagonists and/or acetylcholine receptor ligands; crop protection |
| 08/10/2010 | US7772280 adsorbing onto cation exchange resin, eluting with aqueous alkaline solution, mixing with hydrophilic organic solvent, and crystallizing |
| 08/10/2010 | US7772279 Use of vegetable butter-based cetyl myristoleate for treating osteoarthritis and other musculoskeletal disease conditions and injuries |
| 08/10/2010 | US7772278 Nitrosated and nitrosylated prostaglandins, compositions and methods of use |
| 08/10/2010 | US7772277 pravastatin calcium, omega-3 fatty acid ethyl ester, ethanol, fenofibrate, and surfactants; for reducing or treating elevated cholesterol levels, atherosclerosis, hypertriglyceridemia, coronary artery disease, or cerebrovascular disease |
| 08/10/2010 | US7772276 Exo-selective synthesis of himbacine analogs |
| 08/10/2010 | US7772275 Compositions and method for treating affective, painful or allergic disorders |
| 08/10/2010 | US7772274 solubilizer comprises glycofurol, acetic acid, benzyl alcohol, and/or ethanol; tocopherol polyethylene glycol succinate diluent; storage stability; free of polyethoxylated castor oil; packages |
| 08/10/2010 | US7772272 Method for enhancing glucose uptake into warm-blooded animal adipocytes |
| 08/10/2010 | US7772271 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity |
| 08/10/2010 | US7772270 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects |
| 08/10/2010 | US7772269 Pyrazole analogs |
| 08/10/2010 | US7772268 Diacyl indazole derivatives as lipase and phospholipase inhibitors |
| 08/10/2010 | US7772267 Bicyclic modulators of androgen receptor function |
| 08/10/2010 | US7772266 treating or preventing benign prostatic hyperplasia, enlarged prostate, acute urinary retention with 2-Isopropyl-5-methyl-cyclohexanecarboxylic acid (2-amino-2-phenyl-ethyl)-amide; agonists or antagonists of a transient receptor potential proteins; anticarcinogenic agent |
| 08/10/2010 | US7772264 Such as (S)-1-{[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile mesylate; dipeptidyl peptidase IV inhibitors (DPPIV); for treatment of diabetes, non-insulin dependent diabetes mellitus, impaired glucose tolerance, bowl disease, colitis ulcerosa, morbus crohn, obesity |
| 08/10/2010 | US7772263 Compounds for the treatment of inflammatory disorders |
| 08/10/2010 | US7772262 Substituted benzoylguanidines, method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 08/10/2010 | US7772261 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapeutic application thereof |
| 08/10/2010 | US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
| 08/10/2010 | US7772259 1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 08/10/2010 | US7772258 such as conjunctivitis via administering (+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one; phosphodiesterase inhibitors; for topical administration and for use as drops |
| 08/10/2010 | US7772257 Peroxisome proliferator-activated receptor agonists; insulin resistance; metabolic diseases; diabetes; dyslipidemia; 2-Ethoxy-N-[5-(5-isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-indan-2-yl]-4-trifluoromethyl-benzamide |
| 08/10/2010 | US7772256 2-[6-(methylamino)pyridin-3-yl]-1-benzofuran-5-ol; for imaging amyloid deposits in living patients |
| 08/10/2010 | US7772255 Method of treating tumors with azaxanthones |
| 08/10/2010 | US7772254 Pyridylene compounds used as analgesics and for inhibiting Vanilloid Receptor 1 and metabotropic glutamate receptor 1 function in a cells |
| 08/10/2010 | US7772253 Amide derivatives as somatostatin receptor 5 antagonists |
| 08/10/2010 | US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 08/10/2010 | US7772251 N-sulphonylated amino acid derivatives, method for the production and use thereof |
| 08/10/2010 | US7772250 Compounds |
| 08/10/2010 | US7772249 Imidazo[1,2-b]pyridazine compound |
| 08/10/2010 | US7772248 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 08/10/2010 | US7772247 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) receptor antagonists such as 1-(4-(2-(N-methoxy-N-methylcarbamoyl)thieno[3,2-b]pyridin-7yloxy)-3-fluorophenyl)-3-(2-phenylacetyl)thiourea, used as antiproliferative agents |
| 08/10/2010 | US7772246 3-({4-[1-(2,2-difluoroethyl)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propanenitrile, used as serine/threonine protein kinase inhibitors, for the treatment of disease states associated with abnormal cell growth such as cancer |
| 08/10/2010 | US7772245 [N-hydroxy-4-(1,3,4,9-tetrahydro-2H-b-carbolin-2-yl)benzamide]; antiproliferative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype |
| 08/10/2010 | US7772244 Therapeutic agents for the treatment of migraine |
| 08/10/2010 | US7772243 such as -Piperidin-1-yl-but-2-enoic acid [4(3-chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yl]-amide, used as tyrosine kinase inhibitors, for the prevention of proliferative diseases, including cancer, atherosclerosis, restenosis, endometriosis and psoriasis |
| 08/10/2010 | US7772242 used for protecting human hair and skin against the damaging effect of ultraviolet radiation |
| 08/10/2010 | US7772241 fused pyrido[3'.2':4.5]pyrrolo[1.2-c]pyrimidine's used for treating cancer in mammals |
| 08/10/2010 | US7772240 used for the treatment of psychological disorders such as schizophrenia, anxiety, depression and bipolar disorder |
| 08/10/2010 | US7772239 Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists |
| 08/10/2010 | US7772238 such as N-hydroxy-6-{1-[(4-methoxybenzyl)amino]-2-[(4-methoxyphenyl)amino]-2-oxoethyl}-1-benzothiophene-2-carboxamide, used to treat cancer, tumors, neurodegenerative, autoimmune, allergic and inflammatory diseases, and as histone deacetylase inhibitors |
| 08/10/2010 | US7772237 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 08/10/2010 | US7772236 Substituted pyrazoles |
| 08/10/2010 | US7772235 4-(5-{(1R)-1-[5-(3-Chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,- 4-triazol-3-yl)-1-methylpyridin-2(1H)-one; transient lower esophageal sphincter relaxations; gastroesophageal reflux disease; pain; anxiety; irritable bowel syndrome; metabotropic glutamate receptor inhibitors; peripherally acting |
| 08/10/2010 | US7772234 Bicyclic inhibitors of MEK and methods of use thereof |
| 08/10/2010 | US7772233 Arylamino N-heteroaryl compounds as MEK inhibitors |
| 08/10/2010 | US7772232 Quinazolinyl compounds as inhibitors of potassium channel function |
| 08/10/2010 | US7772231 such as cis-4-(4-(4-amino-3-(2-phenyl-1H-benzimidazol-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl)-1-methylpiperazin-2-one, used as anticarcinogenic agents |
| 08/10/2010 | US7772230 chroman compound, the method of its preparation and pharmaceutical applications. The compound are represented by formula (I) and its pharmaceutical salt, where in :x is for O or S; n is for 2, 3 or 4; R1 is 6-situ or 7-situ halogen, C1-4alkyl, C1-4alkyoxyl, benzyloxy, acylamino; R2 is nitrogen-containin |
| 08/10/2010 | US7772229 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 08/10/2010 | US7772228 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori |
| 08/10/2010 | US7772227 such as (R)-3-Cyclohexyl-2,3-dihydro-6-(4-ethylpiperazin-1-ylcarbonyl)pyrrolo[1,2,3-de]-1,4-benzoxazine hydrochloride salt, used as analgesics for the treatment of post-operative pain, chronic pain neuropathic pain, cancer pain and spasticity associated with multiple sclerosis |
| 08/10/2010 | US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes |
| 08/10/2010 | US7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions |
| 08/10/2010 | US7772224 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches |
| 08/10/2010 | US7772223 Carboxamide derivatives as muscarinic receptor antagonists |
| 08/10/2010 | US7772221 2-ethyl-hexanoic acid ((1S,4R,5S,8S,14R)-5-benzyl-4-hydroxy-18-methoxy-7-oxo-13-oxa-2,6-diaza-tricyclo[12.6.1.015,20]henicosa-10, 15(20),16,18-tetraen-8-yl)-methyl-amide; Alzheimer's Disease, Down's Syndrome; inhibitors of beta-secretase processing of amyloid precursor proteins |
| 08/10/2010 | US7772220 Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 08/10/2010 | US7772219 administering dosage form containing mixture of estrogen and progestin |
| 08/10/2010 | US7772217 For oral administering; mixture of polyunsaturated fatty acid, phospholipids, controller of methionine metabolism such as folic acid, vitamins, minerals, zinc |
| 08/10/2010 | US7772216 enzyme inhibitors comprising 5-fluoroindole-2-carboxamide compounds, used for the treatment cancer, psoriasis, artherosclerosis, non-insulin depepndent diabetes, obesity and as immunomodulators |
| 08/10/2010 | US7772213 such as acne, eczema, shingles, insect bites and hives via cream or ointment containing hydroxypropyl methylcellulose acetate succinate ("HPMCAS") in micronized form |
| 08/10/2010 | US7772212 Isomaltooligosaccharides to inhibit avian pathogenic intestinal bacteria |
| 08/10/2010 | US7772211 shear stress treatment, drying; for use in dairy products, meats, and dessert gels as well as toothpaste formulations, cosmetics, paints, films and delivery capsules |
| 08/10/2010 | US7772210 Cystitis treatment with high dose chondroitin sulfate |
| 08/10/2010 | US7772209 Antifolate combination therapies |
| 08/10/2010 | US7772208 Hepatitis C virus infections; beta -L-2',3'-dideoxy-5-fluorocytidine |
| 08/10/2010 | US7772207 Combination of a CDK inhibitor and CS-682 or a metabolite thereof |
| 08/10/2010 | US7772206 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 08/10/2010 | US7772205 Recombinant plasmid vector; nucleic acid sequence encoding a BMP-7 polypeptide operatively linked to a promoter; IGF-1 signal sequence, tPA signal sequence; signal peptide encoded by a nucleotide sequence; hemodynamic-based plasmid DNA gene delivery; delivery of naked plasmid; occlusion balloon catheter |
| 08/10/2010 | US7772204 heparin sulfate-decorated Perlacan (proteoglycan); administered internally or topically, or is expressed from exogenously added nucleic acids; surgery |
| 08/10/2010 | US7772203 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA |
| 08/10/2010 | US7772201 Using histidine and lysine (HK) as carrier sequences in small interfering RNA transfection complex; for use in prevention and treatment of cell proliferative, muscular, blood, respiratory and nervous system disorders |
| 08/10/2010 | US7772200 iRNA agents targeted to the Rho-A gene |
| 08/10/2010 | US7772199 Forms of 5-azacytidine |
| 08/10/2010 | US7772198 cycstic fibrosis transmembrane conductance regulators (CFTR); for treatment of cystic fibrosis, asthma or diarrhea |
| 08/10/2010 | US7772197 nucleoside or nucleotide analogues; RNA viral diseases |
| 08/10/2010 | US7772196 Skin disorders such as psoriasis or dermatitis; lipid or phospholipid moiety conjugates with monomers, oliogmers or polymers; e.g. phosphatidylethanolamine bound to carboxymethylcellulose, heparin, hyaluronic acid, polyethylene glycol, or polygeline |
| 08/10/2010 | US7772195 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia |
| 08/10/2010 | US7772194 Pesticidal formulations |
| 08/10/2010 | US7772193 mixture of sophorolipids comprises Ethyl 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate or the -6',6''-diacetate; esters of the disaccharide sugar sophorose; saline and glucose, and heparinized sodium-citrate-citric acid-dextrose solution |
| 08/10/2010 | US7772192 Compositions and methods for treatment of disease with acetylated disaccharides |
| 08/10/2010 | US7772191 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein |
| 08/10/2010 | US7772190 E.g., isobutyl N-methyl-N-trimethylallophanoyl-L-alanyl-D-lactate; using parasiticides and nematocides in medicine and veterinary medicine; productive and breeding animals; foods and feeds |
| 08/10/2010 | US7772003 Lipid derivatives of aminoglycosides |
| 08/10/2010 | US7771979 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 08/10/2010 | US7771962 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle |
| 08/10/2010 | US7771931 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease |
| 08/10/2010 | US7771930 Identifying mutation in nucleotide sequences coding immunoglobulin domain carrying polypeptide for use in diagnosis and prognosis of cell proliferative disorders |
| 08/10/2010 | US7771927 Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region |
| 08/10/2010 | US7771771 fatty acid esters of phytosterols and phytostanols; preparing an edible oil or fat blend with elevated sterol and/or stanol content comprising liquid vegetable oil and a sterol and/or stanol fatty acid ester composition |